Literature DB >> 3418645

Physical disability and psychosocial dysfunction in systemic lupus erythematosus.

M C Hochberg1, J D Sutton.   

Abstract

One hundred six ambulatory outpatients with systemic lupus erythematosus (SLE) seen during 1985 completed the Stanford Health Assessment Questionnaire (HAQ) and the Psychosocial Adjustment to Illness Scale (PAIS). Mean HAQ disability, pain and global assessment scores were 0.66, 0.81 and 29.4, respectively, indicating a mild amount of impairment. Significant correlations were observed between increased disability, increased pain and worse global assessment, and poor psychosocial adjustment across all domains of the PAIS. Our data suggest that functional and psychosocial impairment are present in patients with SLE; the use of such measures as outcomes in longitudinal studies is discussed.

Entities:  

Mesh:

Year:  1988        PMID: 3418645

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

1.  Cytokine balance and behavioral intervention; findings from the Peer Approaches to Lupus Self-Management (PALS) project.

Authors:  Edith M Williams; J Madison Hyer; Ramakrishnan Viswanathan; Trevor D Faith; Leonard Egede; Jim C Oates; Gailen D Marshall
Journal:  Hum Immunol       Date:  2017-07-14       Impact factor: 2.850

2.  Chronic pain and impaired glial glutamate transporter function in lupus-prone mice are ameliorated by blocking macrophage colony-stimulating factor-1 receptors.

Authors:  Xisheng Yan; Dylan W Maixner; Fen Li; Han-Rong Weng
Journal:  J Neurochem       Date:  2017-02-01       Impact factor: 5.372

Review 3.  Quality-of-life measurements versus disease activity in systemic lupus erythematosus.

Authors:  Adnan N Kiani; Michelle Petri
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

Review 4.  [Patient-centered assessment of functional health in systemic sclerosis -- where are we now?].

Authors:  T Sigl; T Ewert; G Stucki
Journal:  Z Rheumatol       Date:  2004-12       Impact factor: 1.372

Review 5.  Effective Self-Management Interventions for Patients With Lupus: Potential Impact of Peer Mentoring.

Authors:  Edith M Williams; Leonard Egede; Trevor Faith; James Oates
Journal:  Am J Med Sci       Date:  2017-02-03       Impact factor: 2.378

6.  Activation of microglial GPR109A alleviates thermal hyperalgesia in female lupus mice by suppressing IL-18 and glutamatergic synaptic activity.

Authors:  Viacheslav Viatchenko-Karpinski; Lingwei Kong; Han-Rong Weng
Journal:  Glia       Date:  2021-12-16       Impact factor: 8.073

7.  Health-related quality of life in patients with systemic lupus erythematosus: development and validation of a lupus specific symptom checklist.

Authors:  C Grootscholten; G Ligtenberg; R H W M Derksen; K M G Schreurs; J W de Glas-Vos; E C Hagen; A W L van den Wall Bake; T W J Huizinga; F H J van den Hoogen; M Bijl; J C van Houwelingen; F J Snoek; J H M Berden
Journal:  Qual Life Res       Date:  2003-09       Impact factor: 4.147

Review 8.  Cognitive and emotional abnormalities in systemic lupus erythematosus: evidence for amygdala dysfunction.

Authors:  Philip Watson; Justin Storbeck; Paul Mattis; Meggan Mackay
Journal:  Neuropsychol Rev       Date:  2012-08-11       Impact factor: 7.444

Review 9.  [Psychoimmunology: a questionable model?].

Authors:  D A Vuitton; B de Wazières; J L Dupond
Journal:  Rev Med Interne       Date:  1999-10       Impact factor: 0.728

10.  Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases.

Authors:  C P Denton; J E Pope; H-H Peter; A Gabrielli; A Boonstra; F H J van den Hoogen; G Riemekasten; S De Vita; A Morganti; M Dölberg; O Berkani; L Guillevin
Journal:  Ann Rheum Dis       Date:  2007-11-30       Impact factor: 19.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.